nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Body temperature increased—Captopril—coronary artery disease	0.000152	0.000227	CcSEcCtD
Acamprosate—Dizziness—Simvastatin—coronary artery disease	0.000151	0.000226	CcSEcCtD
Acamprosate—Rash—Ezetimibe—coronary artery disease	0.000151	0.000226	CcSEcCtD
Acamprosate—Dermatitis—Ezetimibe—coronary artery disease	0.000151	0.000226	CcSEcCtD
Acamprosate—Confusional state—Ramipril—coronary artery disease	0.000151	0.000226	CcSEcCtD
Acamprosate—Discomfort—Timolol—coronary artery disease	0.000151	0.000226	CcSEcCtD
Acamprosate—Asthenia—Niacin—coronary artery disease	0.000151	0.000225	CcSEcCtD
Acamprosate—Headache—Ezetimibe—coronary artery disease	0.00015	0.000225	CcSEcCtD
Acamprosate—Malaise—Lisinopril—coronary artery disease	0.00015	0.000224	CcSEcCtD
Acamprosate—Anaphylactic shock—Ramipril—coronary artery disease	0.00015	0.000224	CcSEcCtD
Acamprosate—Vertigo—Lisinopril—coronary artery disease	0.000149	0.000224	CcSEcCtD
Acamprosate—Dry mouth—Timolol—coronary artery disease	0.000149	0.000223	CcSEcCtD
Acamprosate—Constipation—Losartan—coronary artery disease	0.000149	0.000223	CcSEcCtD
Acamprosate—Pain—Losartan—coronary artery disease	0.000149	0.000223	CcSEcCtD
Acamprosate—Syncope—Lisinopril—coronary artery disease	0.000149	0.000223	CcSEcCtD
Acamprosate—Vomiting—Eplerenone—coronary artery disease	0.000149	0.000223	CcSEcCtD
Acamprosate—Feeling abnormal—Furosemide—coronary artery disease	0.000149	0.000223	CcSEcCtD
Acamprosate—Leukopenia—Lisinopril—coronary artery disease	0.000149	0.000223	CcSEcCtD
Acamprosate—Nausea—Fenofibrate—coronary artery disease	0.000149	0.000222	CcSEcCtD
Acamprosate—Pruritus—Niacin—coronary artery disease	0.000149	0.000222	CcSEcCtD
Acamprosate—Asthenia—Pravastatin—coronary artery disease	0.000148	0.000222	CcSEcCtD
Acamprosate—Gastrointestinal pain—Furosemide—coronary artery disease	0.000148	0.000221	CcSEcCtD
Acamprosate—Rash—Eplerenone—coronary artery disease	0.000148	0.000221	CcSEcCtD
Acamprosate—Urticaria—Perindopril—coronary artery disease	0.000148	0.000221	CcSEcCtD
Acamprosate—Hypersensitivity—Trandolapril—coronary artery disease	0.000148	0.000221	CcSEcCtD
Acamprosate—Dermatitis—Eplerenone—coronary artery disease	0.000148	0.000221	CcSEcCtD
Acamprosate—Diarrhoea—Valsartan—coronary artery disease	0.000148	0.000221	CcSEcCtD
Acamprosate—Confusional state—Timolol—coronary artery disease	0.000148	0.000221	CcSEcCtD
Acamprosate—Shock—Ramipril—coronary artery disease	0.000147	0.00022	CcSEcCtD
Acamprosate—Hypersensitivity—Enalapril—coronary artery disease	0.000147	0.00022	CcSEcCtD
Acamprosate—Body temperature increased—Perindopril—coronary artery disease	0.000147	0.00022	CcSEcCtD
Acamprosate—Abdominal pain—Perindopril—coronary artery disease	0.000147	0.00022	CcSEcCtD
Acamprosate—Palpitations—Lisinopril—coronary artery disease	0.000147	0.00022	CcSEcCtD
Acamprosate—Diarrhoea—Olmesartan—coronary artery disease	0.000147	0.00022	CcSEcCtD
Acamprosate—Headache—Eplerenone—coronary artery disease	0.000147	0.00022	CcSEcCtD
Acamprosate—Thrombocytopenia—Ramipril—coronary artery disease	0.000147	0.000219	CcSEcCtD
Acamprosate—Anaphylactic shock—Timolol—coronary artery disease	0.000146	0.000219	CcSEcCtD
Acamprosate—Pruritus—Pravastatin—coronary artery disease	0.000146	0.000219	CcSEcCtD
Acamprosate—Loss of consciousness—Lisinopril—coronary artery disease	0.000146	0.000219	CcSEcCtD
Acamprosate—Nausea—Clopidogrel—coronary artery disease	0.000146	0.000219	CcSEcCtD
Acamprosate—Tachycardia—Ramipril—coronary artery disease	0.000146	0.000219	CcSEcCtD
Acamprosate—Skin disorder—Ramipril—coronary artery disease	0.000145	0.000217	CcSEcCtD
Acamprosate—Infection—Timolol—coronary artery disease	0.000145	0.000217	CcSEcCtD
Acamprosate—Vomiting—Simvastatin—coronary artery disease	0.000145	0.000217	CcSEcCtD
Acamprosate—Hypersensitivity—Telmisartan—coronary artery disease	0.000145	0.000217	CcSEcCtD
Acamprosate—Cough—Lisinopril—coronary artery disease	0.000145	0.000217	CcSEcCtD
Acamprosate—Nausea—Lovastatin—coronary artery disease	0.000145	0.000217	CcSEcCtD
Acamprosate—Hyperhidrosis—Ramipril—coronary artery disease	0.000145	0.000216	CcSEcCtD
Acamprosate—Rash—Simvastatin—coronary artery disease	0.000144	0.000216	CcSEcCtD
Acamprosate—Dermatitis—Simvastatin—coronary artery disease	0.000144	0.000215	CcSEcCtD
Acamprosate—Asthenia—Trandolapril—coronary artery disease	0.000144	0.000215	CcSEcCtD
Acamprosate—Shock—Timolol—coronary artery disease	0.000144	0.000215	CcSEcCtD
Acamprosate—Feeling abnormal—Losartan—coronary artery disease	0.000144	0.000215	CcSEcCtD
Acamprosate—Urticaria—Furosemide—coronary artery disease	0.000144	0.000215	CcSEcCtD
Acamprosate—Diarrhoea—Niacin—coronary artery disease	0.000144	0.000215	CcSEcCtD
Acamprosate—Asthenia—Enalapril—coronary artery disease	0.000143	0.000215	CcSEcCtD
Acamprosate—Headache—Simvastatin—coronary artery disease	0.000143	0.000214	CcSEcCtD
Acamprosate—Abdominal pain—Furosemide—coronary artery disease	0.000143	0.000214	CcSEcCtD
Acamprosate—Body temperature increased—Furosemide—coronary artery disease	0.000143	0.000214	CcSEcCtD
Acamprosate—Gastrointestinal pain—Losartan—coronary artery disease	0.000143	0.000214	CcSEcCtD
Acamprosate—Dizziness—Valsartan—coronary artery disease	0.000143	0.000214	CcSEcCtD
Acamprosate—Anorexia—Ramipril—coronary artery disease	0.000143	0.000213	CcSEcCtD
Acamprosate—Nausea—Ezetimibe—coronary artery disease	0.000142	0.000213	CcSEcCtD
Acamprosate—Skin disorder—Timolol—coronary artery disease	0.000142	0.000213	CcSEcCtD
Acamprosate—Dizziness—Olmesartan—coronary artery disease	0.000142	0.000212	CcSEcCtD
Acamprosate—Pruritus—Trandolapril—coronary artery disease	0.000142	0.000212	CcSEcCtD
Acamprosate—Arthralgia—Lisinopril—coronary artery disease	0.000142	0.000212	CcSEcCtD
Acamprosate—Chest pain—Lisinopril—coronary artery disease	0.000142	0.000212	CcSEcCtD
Acamprosate—Myalgia—Lisinopril—coronary artery disease	0.000142	0.000212	CcSEcCtD
Acamprosate—Hyperhidrosis—Timolol—coronary artery disease	0.000141	0.000212	CcSEcCtD
Acamprosate—Asthenia—Telmisartan—coronary artery disease	0.000141	0.000212	CcSEcCtD
Acamprosate—Pruritus—Enalapril—coronary artery disease	0.000141	0.000212	CcSEcCtD
Acamprosate—Diarrhoea—Pravastatin—coronary artery disease	0.000141	0.000211	CcSEcCtD
Acamprosate—Anxiety—Lisinopril—coronary artery disease	0.000141	0.000211	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000141	0.00021	CcSEcCtD
Acamprosate—Discomfort—Lisinopril—coronary artery disease	0.00014	0.000209	CcSEcCtD
Acamprosate—Hypotension—Ramipril—coronary artery disease	0.00014	0.000209	CcSEcCtD
Acamprosate—Anorexia—Timolol—coronary artery disease	0.00014	0.000209	CcSEcCtD
Acamprosate—Pruritus—Telmisartan—coronary artery disease	0.000139	0.000209	CcSEcCtD
Acamprosate—Nausea—Eplerenone—coronary artery disease	0.000139	0.000208	CcSEcCtD
Acamprosate—Dizziness—Niacin—coronary artery disease	0.000139	0.000208	CcSEcCtD
Acamprosate—Urticaria—Losartan—coronary artery disease	0.000139	0.000207	CcSEcCtD
Acamprosate—Dry mouth—Lisinopril—coronary artery disease	0.000139	0.000207	CcSEcCtD
Acamprosate—Abdominal pain—Losartan—coronary artery disease	0.000138	0.000206	CcSEcCtD
Acamprosate—Body temperature increased—Losartan—coronary artery disease	0.000138	0.000206	CcSEcCtD
Acamprosate—Asthenia—Captopril—coronary artery disease	0.000138	0.000206	CcSEcCtD
Acamprosate—Diarrhoea—Trandolapril—coronary artery disease	0.000137	0.000205	CcSEcCtD
Acamprosate—Vomiting—Valsartan—coronary artery disease	0.000137	0.000205	CcSEcCtD
Acamprosate—Confusional state—Lisinopril—coronary artery disease	0.000137	0.000205	CcSEcCtD
Acamprosate—Diarrhoea—Enalapril—coronary artery disease	0.000137	0.000205	CcSEcCtD
Acamprosate—Hypotension—Timolol—coronary artery disease	0.000137	0.000205	CcSEcCtD
Acamprosate—Dizziness—Pravastatin—coronary artery disease	0.000137	0.000204	CcSEcCtD
Acamprosate—Vomiting—Olmesartan—coronary artery disease	0.000137	0.000204	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000136	0.000204	CcSEcCtD
Acamprosate—Rash—Valsartan—coronary artery disease	0.000136	0.000204	CcSEcCtD
Acamprosate—Dermatitis—Valsartan—coronary artery disease	0.000136	0.000203	CcSEcCtD
Acamprosate—Nausea—Simvastatin—coronary artery disease	0.000136	0.000203	CcSEcCtD
Acamprosate—Anaphylactic shock—Lisinopril—coronary artery disease	0.000136	0.000203	CcSEcCtD
Acamprosate—Pruritus—Captopril—coronary artery disease	0.000136	0.000203	CcSEcCtD
Acamprosate—Rash—Olmesartan—coronary artery disease	0.000135	0.000203	CcSEcCtD
Acamprosate—Insomnia—Ramipril—coronary artery disease	0.000135	0.000203	CcSEcCtD
Acamprosate—Dermatitis—Olmesartan—coronary artery disease	0.000135	0.000202	CcSEcCtD
Acamprosate—Headache—Valsartan—coronary artery disease	0.000135	0.000202	CcSEcCtD
Acamprosate—Diarrhoea—Telmisartan—coronary artery disease	0.000135	0.000202	CcSEcCtD
Acamprosate—Infection—Lisinopril—coronary artery disease	0.000135	0.000202	CcSEcCtD
Acamprosate—Headache—Olmesartan—coronary artery disease	0.000135	0.000201	CcSEcCtD
Acamprosate—Paraesthesia—Ramipril—coronary artery disease	0.000134	0.000201	CcSEcCtD
Acamprosate—Shock—Lisinopril—coronary artery disease	0.000134	0.0002	CcSEcCtD
Acamprosate—Asthenia—Perindopril—coronary artery disease	0.000134	0.0002	CcSEcCtD
Acamprosate—Dyspnoea—Ramipril—coronary artery disease	0.000133	0.0002	CcSEcCtD
Acamprosate—Vomiting—Niacin—coronary artery disease	0.000133	0.0002	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000133	0.000199	CcSEcCtD
Acamprosate—Hypersensitivity—Furosemide—coronary artery disease	0.000133	0.000199	CcSEcCtD
Acamprosate—Somnolence—Ramipril—coronary artery disease	0.000133	0.000199	CcSEcCtD
Acamprosate—Thrombocytopenia—Lisinopril—coronary artery disease	0.000133	0.000199	CcSEcCtD
Acamprosate—Dizziness—Trandolapril—coronary artery disease	0.000133	0.000198	CcSEcCtD
Acamprosate—Tachycardia—Lisinopril—coronary artery disease	0.000133	0.000198	CcSEcCtD
Acamprosate—Insomnia—Timolol—coronary artery disease	0.000132	0.000198	CcSEcCtD
Acamprosate—Rash—Niacin—coronary artery disease	0.000132	0.000198	CcSEcCtD
Acamprosate—Dermatitis—Niacin—coronary artery disease	0.000132	0.000198	CcSEcCtD
Acamprosate—Dizziness—Enalapril—coronary artery disease	0.000132	0.000198	CcSEcCtD
Acamprosate—Skin disorder—Lisinopril—coronary artery disease	0.000132	0.000197	CcSEcCtD
Acamprosate—Dyspepsia—Ramipril—coronary artery disease	0.000132	0.000197	CcSEcCtD
Acamprosate—Pruritus—Perindopril—coronary artery disease	0.000132	0.000197	CcSEcCtD
Acamprosate—Headache—Niacin—coronary artery disease	0.000131	0.000197	CcSEcCtD
Acamprosate—Paraesthesia—Timolol—coronary artery disease	0.000131	0.000197	CcSEcCtD
Acamprosate—Vomiting—Pravastatin—coronary artery disease	0.000131	0.000197	CcSEcCtD
Acamprosate—Hyperhidrosis—Lisinopril—coronary artery disease	0.000131	0.000196	CcSEcCtD
Acamprosate—Diarrhoea—Captopril—coronary artery disease	0.000131	0.000196	CcSEcCtD
Acamprosate—Dyspnoea—Timolol—coronary artery disease	0.00013	0.000195	CcSEcCtD
Acamprosate—Dizziness—Telmisartan—coronary artery disease	0.00013	0.000195	CcSEcCtD
Acamprosate—Rash—Pravastatin—coronary artery disease	0.00013	0.000195	CcSEcCtD
Acamprosate—Dermatitis—Pravastatin—coronary artery disease	0.00013	0.000195	CcSEcCtD
Acamprosate—Decreased appetite—Ramipril—coronary artery disease	0.00013	0.000195	CcSEcCtD
Acamprosate—Somnolence—Timolol—coronary artery disease	0.00013	0.000195	CcSEcCtD
Acamprosate—Asthenia—Furosemide—coronary artery disease	0.00013	0.000194	CcSEcCtD
Acamprosate—Headache—Pravastatin—coronary artery disease	0.000129	0.000194	CcSEcCtD
Acamprosate—Anorexia—Lisinopril—coronary artery disease	0.000129	0.000194	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000129	0.000193	CcSEcCtD
Acamprosate—Dyspepsia—Timolol—coronary artery disease	0.000129	0.000193	CcSEcCtD
Acamprosate—Hypersensitivity—Losartan—coronary artery disease	0.000129	0.000192	CcSEcCtD
Acamprosate—Nausea—Valsartan—coronary artery disease	0.000128	0.000192	CcSEcCtD
Acamprosate—Pruritus—Furosemide—coronary artery disease	0.000128	0.000191	CcSEcCtD
Acamprosate—Constipation—Ramipril—coronary artery disease	0.000128	0.000191	CcSEcCtD
Acamprosate—Nausea—Olmesartan—coronary artery disease	0.000128	0.000191	CcSEcCtD
Acamprosate—Vomiting—Trandolapril—coronary artery disease	0.000128	0.000191	CcSEcCtD
Acamprosate—Diarrhoea—Perindopril—coronary artery disease	0.000127	0.00019	CcSEcCtD
Acamprosate—Decreased appetite—Timolol—coronary artery disease	0.000127	0.00019	CcSEcCtD
Acamprosate—Vomiting—Enalapril—coronary artery disease	0.000127	0.00019	CcSEcCtD
Acamprosate—Hypotension—Lisinopril—coronary artery disease	0.000127	0.00019	CcSEcCtD
Acamprosate—Dizziness—Captopril—coronary artery disease	0.000127	0.00019	CcSEcCtD
Acamprosate—Rash—Trandolapril—coronary artery disease	0.000127	0.000189	CcSEcCtD
Acamprosate—Dermatitis—Trandolapril—coronary artery disease	0.000126	0.000189	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Timolol—coronary artery disease	0.000126	0.000189	CcSEcCtD
Acamprosate—Rash—Enalapril—coronary artery disease	0.000126	0.000189	CcSEcCtD
Acamprosate—Dermatitis—Enalapril—coronary artery disease	0.000126	0.000188	CcSEcCtD
Acamprosate—Headache—Trandolapril—coronary artery disease	0.000126	0.000188	CcSEcCtD
Acamprosate—Vomiting—Telmisartan—coronary artery disease	0.000125	0.000187	CcSEcCtD
Acamprosate—Asthenia—Losartan—coronary artery disease	0.000125	0.000187	CcSEcCtD
Acamprosate—Headache—Enalapril—coronary artery disease	0.000125	0.000187	CcSEcCtD
Acamprosate—Pain—Timolol—coronary artery disease	0.000125	0.000187	CcSEcCtD
Acamprosate—Nausea—Niacin—coronary artery disease	0.000125	0.000186	CcSEcCtD
Acamprosate—Rash—Telmisartan—coronary artery disease	0.000124	0.000186	CcSEcCtD
Acamprosate—Dermatitis—Telmisartan—coronary artery disease	0.000124	0.000186	CcSEcCtD
Acamprosate—Diarrhoea—Furosemide—coronary artery disease	0.000124	0.000185	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000124	0.000185	CcSEcCtD
Acamprosate—Pruritus—Losartan—coronary artery disease	0.000124	0.000185	CcSEcCtD
Acamprosate—Headache—Telmisartan—coronary artery disease	0.000124	0.000185	CcSEcCtD
Acamprosate—Feeling abnormal—Ramipril—coronary artery disease	0.000123	0.000185	CcSEcCtD
Acamprosate—Dizziness—Perindopril—coronary artery disease	0.000123	0.000184	CcSEcCtD
Acamprosate—Insomnia—Lisinopril—coronary artery disease	0.000123	0.000184	CcSEcCtD
Acamprosate—Nausea—Pravastatin—coronary artery disease	0.000123	0.000184	CcSEcCtD
Acamprosate—Gastrointestinal pain—Ramipril—coronary artery disease	0.000122	0.000183	CcSEcCtD
Acamprosate—Paraesthesia—Lisinopril—coronary artery disease	0.000122	0.000182	CcSEcCtD
Acamprosate—Vomiting—Captopril—coronary artery disease	0.000122	0.000182	CcSEcCtD
Acamprosate—Dyspnoea—Lisinopril—coronary artery disease	0.000121	0.000181	CcSEcCtD
Acamprosate—Rash—Captopril—coronary artery disease	0.000121	0.000181	CcSEcCtD
Acamprosate—Dermatitis—Captopril—coronary artery disease	0.000121	0.000181	CcSEcCtD
Acamprosate—Somnolence—Lisinopril—coronary artery disease	0.000121	0.000181	CcSEcCtD
Acamprosate—Feeling abnormal—Timolol—coronary artery disease	0.000121	0.00018	CcSEcCtD
Acamprosate—Headache—Captopril—coronary artery disease	0.00012	0.00018	CcSEcCtD
Acamprosate—Gastrointestinal pain—Timolol—coronary artery disease	0.00012	0.000179	CcSEcCtD
Acamprosate—Dizziness—Furosemide—coronary artery disease	0.00012	0.000179	CcSEcCtD
Acamprosate—Dyspepsia—Lisinopril—coronary artery disease	0.00012	0.000179	CcSEcCtD
Acamprosate—Diarrhoea—Losartan—coronary artery disease	0.000119	0.000179	CcSEcCtD
Acamprosate—Nausea—Trandolapril—coronary artery disease	0.000119	0.000178	CcSEcCtD
Acamprosate—Urticaria—Ramipril—coronary artery disease	0.000119	0.000178	CcSEcCtD
Acamprosate—Nausea—Enalapril—coronary artery disease	0.000119	0.000178	CcSEcCtD
Acamprosate—Vomiting—Perindopril—coronary artery disease	0.000118	0.000177	CcSEcCtD
Acamprosate—Abdominal pain—Ramipril—coronary artery disease	0.000118	0.000177	CcSEcCtD
Acamprosate—Body temperature increased—Ramipril—coronary artery disease	0.000118	0.000177	CcSEcCtD
Acamprosate—Decreased appetite—Lisinopril—coronary artery disease	0.000118	0.000177	CcSEcCtD
Acamprosate—Rash—Perindopril—coronary artery disease	0.000117	0.000176	CcSEcCtD
Acamprosate—Dermatitis—Perindopril—coronary artery disease	0.000117	0.000175	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000117	0.000175	CcSEcCtD
Acamprosate—Nausea—Telmisartan—coronary artery disease	0.000117	0.000175	CcSEcCtD
Acamprosate—Headache—Perindopril—coronary artery disease	0.000117	0.000174	CcSEcCtD
Acamprosate—Urticaria—Timolol—coronary artery disease	0.000116	0.000174	CcSEcCtD
Acamprosate—Pain—Lisinopril—coronary artery disease	0.000116	0.000174	CcSEcCtD
Acamprosate—Constipation—Lisinopril—coronary artery disease	0.000116	0.000174	CcSEcCtD
Acamprosate—Abdominal pain—Timolol—coronary artery disease	0.000116	0.000173	CcSEcCtD
Acamprosate—Body temperature increased—Timolol—coronary artery disease	0.000116	0.000173	CcSEcCtD
Acamprosate—Dizziness—Losartan—coronary artery disease	0.000115	0.000173	CcSEcCtD
Acamprosate—Vomiting—Furosemide—coronary artery disease	0.000115	0.000172	CcSEcCtD
Acamprosate—Rash—Furosemide—coronary artery disease	0.000114	0.000171	CcSEcCtD
Acamprosate—Dermatitis—Furosemide—coronary artery disease	0.000114	0.00017	CcSEcCtD
Acamprosate—Nausea—Captopril—coronary artery disease	0.000114	0.00017	CcSEcCtD
Acamprosate—Headache—Furosemide—coronary artery disease	0.000113	0.00017	CcSEcCtD
Acamprosate—Feeling abnormal—Lisinopril—coronary artery disease	0.000112	0.000167	CcSEcCtD
Acamprosate—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000111	0.000166	CcSEcCtD
Acamprosate—Vomiting—Losartan—coronary artery disease	0.000111	0.000166	CcSEcCtD
Acamprosate—Nausea—Perindopril—coronary artery disease	0.000111	0.000165	CcSEcCtD
Acamprosate—Hypersensitivity—Ramipril—coronary artery disease	0.00011	0.000165	CcSEcCtD
Acamprosate—Rash—Losartan—coronary artery disease	0.00011	0.000165	CcSEcCtD
Acamprosate—Dermatitis—Losartan—coronary artery disease	0.00011	0.000164	CcSEcCtD
Acamprosate—Headache—Losartan—coronary artery disease	0.000109	0.000164	CcSEcCtD
Acamprosate—Urticaria—Lisinopril—coronary artery disease	0.000108	0.000161	CcSEcCtD
Acamprosate—Hypersensitivity—Timolol—coronary artery disease	0.000108	0.000161	CcSEcCtD
Acamprosate—Nausea—Furosemide—coronary artery disease	0.000107	0.000161	CcSEcCtD
Acamprosate—Asthenia—Ramipril—coronary artery disease	0.000107	0.000161	CcSEcCtD
Acamprosate—Abdominal pain—Lisinopril—coronary artery disease	0.000107	0.000161	CcSEcCtD
Acamprosate—Body temperature increased—Lisinopril—coronary artery disease	0.000107	0.000161	CcSEcCtD
Acamprosate—Pruritus—Ramipril—coronary artery disease	0.000106	0.000158	CcSEcCtD
Acamprosate—Asthenia—Timolol—coronary artery disease	0.000105	0.000157	CcSEcCtD
Acamprosate—Nausea—Losartan—coronary artery disease	0.000104	0.000155	CcSEcCtD
Acamprosate—Pruritus—Timolol—coronary artery disease	0.000104	0.000155	CcSEcCtD
Acamprosate—Diarrhoea—Ramipril—coronary artery disease	0.000102	0.000153	CcSEcCtD
Acamprosate—Diarrhoea—Timolol—coronary artery disease	0.0001	0.00015	CcSEcCtD
Acamprosate—Hypersensitivity—Lisinopril—coronary artery disease	0.0001	0.00015	CcSEcCtD
Acamprosate—Dizziness—Ramipril—coronary artery disease	9.9e-05	0.000148	CcSEcCtD
Acamprosate—Asthenia—Lisinopril—coronary artery disease	9.74e-05	0.000146	CcSEcCtD
Acamprosate—Dizziness—Timolol—coronary artery disease	9.68e-05	0.000145	CcSEcCtD
Acamprosate—Pruritus—Lisinopril—coronary artery disease	9.61e-05	0.000144	CcSEcCtD
Acamprosate—Vomiting—Ramipril—coronary artery disease	9.52e-05	0.000142	CcSEcCtD
Acamprosate—Rash—Ramipril—coronary artery disease	9.44e-05	0.000141	CcSEcCtD
Acamprosate—Dermatitis—Ramipril—coronary artery disease	9.43e-05	0.000141	CcSEcCtD
Acamprosate—Headache—Ramipril—coronary artery disease	9.38e-05	0.00014	CcSEcCtD
Acamprosate—Vomiting—Timolol—coronary artery disease	9.31e-05	0.000139	CcSEcCtD
Acamprosate—Diarrhoea—Lisinopril—coronary artery disease	9.29e-05	0.000139	CcSEcCtD
Acamprosate—Rash—Timolol—coronary artery disease	9.23e-05	0.000138	CcSEcCtD
Acamprosate—Dermatitis—Timolol—coronary artery disease	9.22e-05	0.000138	CcSEcCtD
Acamprosate—Headache—Timolol—coronary artery disease	9.17e-05	0.000137	CcSEcCtD
Acamprosate—Dizziness—Lisinopril—coronary artery disease	8.98e-05	0.000134	CcSEcCtD
Acamprosate—Nausea—Ramipril—coronary artery disease	8.89e-05	0.000133	CcSEcCtD
Acamprosate—Nausea—Timolol—coronary artery disease	8.69e-05	0.00013	CcSEcCtD
Acamprosate—Vomiting—Lisinopril—coronary artery disease	8.63e-05	0.000129	CcSEcCtD
Acamprosate—Rash—Lisinopril—coronary artery disease	8.56e-05	0.000128	CcSEcCtD
Acamprosate—Dermatitis—Lisinopril—coronary artery disease	8.55e-05	0.000128	CcSEcCtD
Acamprosate—Headache—Lisinopril—coronary artery disease	8.51e-05	0.000127	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—EDNRB—coronary artery disease	8.24e-05	0.000249	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PLCB1—coronary artery disease	8.2e-05	0.000247	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	8.19e-05	0.000247	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HK1—coronary artery disease	8.19e-05	0.000247	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	8.19e-05	0.000247	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—MAPK1—coronary artery disease	8.17e-05	0.000246	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—THBS1—coronary artery disease	8.12e-05	0.000245	CbGpPWpGaD
Acamprosate—Nausea—Lisinopril—coronary artery disease	8.06e-05	0.000121	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PSMB5—coronary artery disease	8.04e-05	0.000243	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PSMA6—coronary artery disease	8.04e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KDR—coronary artery disease	8.02e-05	0.000242	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—F2—coronary artery disease	8.02e-05	0.000242	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	7.93e-05	0.000239	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—CREB1—coronary artery disease	7.93e-05	0.000239	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGT—coronary artery disease	7.88e-05	0.000238	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KDR—coronary artery disease	7.82e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—coronary artery disease	7.79e-05	0.000235	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	7.78e-05	0.000235	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDNRA—coronary artery disease	7.78e-05	0.000235	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	7.76e-05	0.000234	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	7.76e-05	0.000234	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB1—coronary artery disease	7.75e-05	0.000234	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CYBA—coronary artery disease	7.75e-05	0.000234	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—CREB1—coronary artery disease	7.73e-05	0.000233	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DUSP6—coronary artery disease	7.71e-05	0.000233	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6ST—coronary artery disease	7.69e-05	0.000232	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARGC1A—coronary artery disease	7.66e-05	0.000231	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—MAPK1—coronary artery disease	7.61e-05	0.00023	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	7.59e-05	0.000229	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLAT—coronary artery disease	7.58e-05	0.000229	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JAK2—coronary artery disease	7.52e-05	0.000227	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6ST—coronary artery disease	7.5e-05	0.000226	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARGC1A—coronary artery disease	7.46e-05	0.000225	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK1—coronary artery disease	7.42e-05	0.000224	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BDKRB2—coronary artery disease	7.32e-05	0.000221	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL12—coronary artery disease	7.32e-05	0.000221	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—coronary artery disease	7.31e-05	0.00022	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—F2—coronary artery disease	7.28e-05	0.00022	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6ST—coronary artery disease	7.25e-05	0.000219	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUNB—coronary artery disease	7.18e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HK1—coronary artery disease	7.16e-05	0.000216	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	7.16e-05	0.000216	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	7.16e-05	0.000216	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLCB1—coronary artery disease	7.16e-05	0.000216	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CREB1—coronary artery disease	7.15e-05	0.000216	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—GSK3B—coronary artery disease	7.09e-05	0.000214	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—CREB1—coronary artery disease	7.03e-05	0.000212	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR7—coronary artery disease	7.01e-05	0.000211	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6R—coronary artery disease	6.97e-05	0.00021	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LPL—coronary artery disease	6.97e-05	0.00021	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—coronary artery disease	6.91e-05	0.000209	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—GSK3B—coronary artery disease	6.91e-05	0.000209	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MEF2C—coronary artery disease	6.91e-05	0.000208	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6R—coronary artery disease	6.86e-05	0.000207	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—coronary artery disease	6.86e-05	0.000207	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—CREB1—coronary artery disease	6.86e-05	0.000207	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CREB1—coronary artery disease	6.83e-05	0.000206	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—coronary artery disease	6.8e-05	0.000205	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LPL—coronary artery disease	6.8e-05	0.000205	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MEF2C—coronary artery disease	6.73e-05	0.000203	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MAPK1—coronary artery disease	6.73e-05	0.000203	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ITGB3—coronary artery disease	6.73e-05	0.000203	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAPK1—coronary artery disease	6.71e-05	0.000202	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CREB1—coronary artery disease	6.7e-05	0.000202	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6R—coronary artery disease	6.69e-05	0.000202	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITGAV—coronary artery disease	6.68e-05	0.000201	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KNG1—coronary artery disease	6.66e-05	0.000201	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—POMC—coronary artery disease	6.63e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CREB1—coronary artery disease	6.63e-05	0.0002	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CD36—coronary artery disease	6.62e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGTR1—coronary artery disease	6.62e-05	0.0002	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—coronary artery disease	6.57e-05	0.000198	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ITGB3—coronary artery disease	6.56e-05	0.000198	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—coronary artery disease	6.55e-05	0.000198	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—coronary artery disease	6.49e-05	0.000196	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6R—coronary artery disease	6.47e-05	0.000195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL10—coronary artery disease	6.47e-05	0.000195	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CD36—coronary artery disease	6.46e-05	0.000195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLG—coronary artery disease	6.45e-05	0.000195	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.4e-05	0.000193	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—coronary artery disease	6.38e-05	0.000193	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	6.28e-05	0.00019	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB2—coronary artery disease	6.28e-05	0.000189	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—MAPK1—coronary artery disease	6.26e-05	0.000189	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.25e-05	0.000188	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCE—coronary artery disease	6.2e-05	0.000187	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—JAK2—coronary artery disease	6.19e-05	0.000187	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SOCS1—coronary artery disease	6.18e-05	0.000187	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CETP—coronary artery disease	6.17e-05	0.000186	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—S100B—coronary artery disease	6.17e-05	0.000186	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	6.13e-05	0.000185	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SOCS3—coronary artery disease	6.11e-05	0.000184	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CETP—coronary artery disease	6.06e-05	0.000183	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KITLG—coronary artery disease	6.03e-05	0.000182	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFBR2—coronary artery disease	6.03e-05	0.000182	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—JAK2—coronary artery disease	5.96e-05	0.00018	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP3—coronary artery disease	5.9e-05	0.000178	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT5A—coronary artery disease	5.9e-05	0.000178	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CREB1—coronary artery disease	5.86e-05	0.000177	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.85e-05	0.000177	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAPK1—coronary artery disease	5.85e-05	0.000177	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—coronary artery disease	5.84e-05	0.000176	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—JAK2—coronary artery disease	5.81e-05	0.000175	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.75e-05	0.000173	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—coronary artery disease	5.72e-05	0.000173	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAPK1—coronary artery disease	5.7e-05	0.000172	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOB—coronary artery disease	5.7e-05	0.000172	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—coronary artery disease	5.7e-05	0.000172	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK14—coronary artery disease	5.69e-05	0.000172	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—coronary artery disease	5.65e-05	0.000171	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—JAK2—coronary artery disease	5.62e-05	0.00017	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDN1—coronary artery disease	5.61e-05	0.000169	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—coronary artery disease	5.58e-05	0.000168	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL5—coronary artery disease	5.57e-05	0.000168	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK14—coronary artery disease	5.54e-05	0.000167	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	5.53e-05	0.000167	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	5.49e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6ST—coronary artery disease	5.49e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—coronary artery disease	5.48e-05	0.000165	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF1—coronary artery disease	5.48e-05	0.000165	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2—coronary artery disease	5.48e-05	0.000165	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LPL—coronary artery disease	5.44e-05	0.000164	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.44e-05	0.000164	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—coronary artery disease	5.39e-05	0.000163	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RPS6KB1—coronary artery disease	5.39e-05	0.000163	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MEF2C—coronary artery disease	5.39e-05	0.000163	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	5.36e-05	0.000162	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6ST—coronary artery disease	5.35e-05	0.000161	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLAT—coronary artery disease	5.34e-05	0.000161	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—coronary artery disease	5.3e-05	0.00016	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CETP—coronary artery disease	5.3e-05	0.00016	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—coronary artery disease	5.29e-05	0.00016	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—coronary artery disease	5.26e-05	0.000159	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITGB3—coronary artery disease	5.26e-05	0.000159	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—CREB1—coronary artery disease	5.23e-05	0.000158	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAPK1—coronary artery disease	5.14e-05	0.000155	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CREB1—coronary artery disease	5.14e-05	0.000155	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	5.13e-05	0.000155	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—coronary artery disease	5.13e-05	0.000155	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PPP2CA—coronary artery disease	5.11e-05	0.000154	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—coronary artery disease	5.09e-05	0.000154	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—GSK3B—coronary artery disease	5.06e-05	0.000153	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	5.04e-05	0.000152	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TFRC—coronary artery disease	5.02e-05	0.000152	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK1—coronary artery disease	5.02e-05	0.000151	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CREB1—coronary artery disease	5.02e-05	0.000151	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCD—coronary artery disease	5.01e-05	0.000151	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—coronary artery disease	4.96e-05	0.00015	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—GSK3B—coronary artery disease	4.93e-05	0.000149	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—coronary artery disease	4.92e-05	0.000148	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—coronary artery disease	4.91e-05	0.000148	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—coronary artery disease	4.9e-05	0.000148	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6R—coronary artery disease	4.9e-05	0.000148	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CREB1—coronary artery disease	4.89e-05	0.000148	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—coronary artery disease	4.8e-05	0.000145	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6R—coronary artery disease	4.77e-05	0.000144	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—coronary artery disease	4.67e-05	0.000141	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—coronary artery disease	4.67e-05	0.000141	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLAT—coronary artery disease	4.67e-05	0.000141	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGT—coronary artery disease	4.66e-05	0.00014	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLG—coronary artery disease	4.63e-05	0.00014	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—coronary artery disease	4.56e-05	0.000138	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—coronary artery disease	4.56e-05	0.000138	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—coronary artery disease	4.55e-05	0.000137	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLG—coronary artery disease	4.54e-05	0.000137	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA1—coronary artery disease	4.51e-05	0.000136	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	4.49e-05	0.000135	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CREB1—coronary artery disease	4.49e-05	0.000135	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAPK1—coronary artery disease	4.48e-05	0.000135	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—coronary artery disease	4.47e-05	0.000135	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK14—coronary artery disease	4.44e-05	0.000134	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGF2—coronary artery disease	4.44e-05	0.000134	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—coronary artery disease	4.42e-05	0.000133	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—coronary artery disease	4.41e-05	0.000133	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MAPK1—coronary artery disease	4.37e-05	0.000132	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—coronary artery disease	4.36e-05	0.000131	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGF2—coronary artery disease	4.33e-05	0.000131	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—coronary artery disease	4.31e-05	0.00013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—coronary artery disease	4.3e-05	0.00013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FN1—coronary artery disease	4.3e-05	0.00013	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6ST—coronary artery disease	4.28e-05	0.000129	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.27e-05	0.000129	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—JAK2—coronary artery disease	4.25e-05	0.000128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKBIA—coronary artery disease	4.25e-05	0.000128	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.19e-05	0.000127	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—JAK2—coronary artery disease	4.15e-05	0.000125	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—coronary artery disease	4.12e-05	0.000124	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOB—coronary artery disease	4.09e-05	0.000123	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOB—coronary artery disease	4.02e-05	0.000121	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK1—coronary artery disease	3.98e-05	0.00012	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLG—coronary artery disease	3.97e-05	0.00012	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GSK3B—coronary artery disease	3.95e-05	0.000119	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—coronary artery disease	3.92e-05	0.000118	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CREB1—coronary artery disease	3.92e-05	0.000118	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK1—coronary artery disease	3.88e-05	0.000117	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.86e-05	0.000116	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—coronary artery disease	3.85e-05	0.000116	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—coronary artery disease	3.83e-05	0.000116	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6R—coronary artery disease	3.82e-05	0.000115	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.79e-05	0.000114	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—coronary artery disease	3.77e-05	0.000114	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK1—coronary artery disease	3.75e-05	0.000113	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	3.66e-05	0.000111	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—coronary artery disease	3.58e-05	0.000108	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—coronary artery disease	3.58e-05	0.000108	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—coronary artery disease	3.56e-05	0.000107	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—coronary artery disease	3.51e-05	0.000106	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOB—coronary artery disease	3.51e-05	0.000106	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF2—coronary artery disease	3.47e-05	0.000105	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—coronary artery disease	3.42e-05	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—coronary artery disease	3.42e-05	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JAK2—coronary artery disease	3.32e-05	0.0001	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAPK1—coronary artery disease	3.31e-05	0.0001	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—coronary artery disease	3.26e-05	9.82e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.24e-05	9.76e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.18e-05	9.59e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—coronary artery disease	3.15e-05	9.52e-05	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—coronary artery disease	3.11e-05	9.37e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—coronary artery disease	3.07e-05	9.28e-05	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—coronary artery disease	3.06e-05	9.22e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—coronary artery disease	3.03e-05	9.15e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—coronary artery disease	2.98e-05	8.99e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAPK1—coronary artery disease	2.96e-05	8.92e-05	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—coronary artery disease	2.93e-05	8.84e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAPK1—coronary artery disease	2.9e-05	8.76e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—coronary artery disease	2.9e-05	8.75e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—coronary artery disease	2.89e-05	8.73e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—coronary artery disease	2.88e-05	8.7e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK1—coronary artery disease	2.84e-05	8.56e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—coronary artery disease	2.82e-05	8.52e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—coronary artery disease	2.82e-05	8.51e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.78e-05	8.38e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK1—coronary artery disease	2.77e-05	8.35e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—coronary artery disease	2.74e-05	8.27e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—coronary artery disease	2.7e-05	8.16e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—coronary artery disease	2.66e-05	8.02e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—coronary artery disease	2.63e-05	7.95e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—coronary artery disease	2.56e-05	7.74e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAPK1—coronary artery disease	2.54e-05	7.66e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.52e-05	7.6e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—coronary artery disease	2.46e-05	7.43e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—coronary artery disease	2.26e-05	6.82e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK1—coronary artery disease	2.22e-05	6.69e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.2e-05	6.64e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—coronary artery disease	2.18e-05	6.58e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—coronary artery disease	2.13e-05	6.42e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—coronary artery disease	2.01e-05	6.07e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—coronary artery disease	1.96e-05	5.92e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—coronary artery disease	1.92e-05	5.8e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—coronary artery disease	1.7e-05	5.14e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—coronary artery disease	1.57e-05	4.74e-05	CbGpPWpGaD
